Stay updated on Inhaled GB002 for PAH: Phase III Clinical Trial

Sign up to get notified when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled GB002 for PAH: Phase III Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.6.5 in place of v3.6.4, signaling a platform version update to the record history interface.
    Difference
    0.1%
    Check dated 2026-08-08T10:26:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The sponsor subsidiary name is updated from Gossamer Bio Inc. to Gossamer Bio USA, Inc., and the revision/version is updated from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-25T06:39:30.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A new revision, v3.6.3, appears in the record history, indicating an updated version of the page. The previous revision, v3.6.2, is no longer the latest entry in the history.
    Difference
    0.1%
    Check dated 2026-07-03T22:37:29.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new latest revision v3.6.2 is added to the record history and the older revision v3.6.0 is removed, reflecting an update to the study record's version history.
    Difference
    0.1%
    Check dated 2026-06-27T00:28:36.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The recruitment status was updated to no longer looking for participants, indicating the study is not seeking new participants. The history also notes a new revision (v3.6.0) and the deletion of the prior revision (v3.5.5).
    Difference
    0.3%
    Check dated 2026-06-12T16:30:23.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the study record history metadata rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-05T11:26:37.000Z thumbnail image

Stay in the know with updates to Inhaled GB002 for PAH: Phase III Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.